Dear Valued Clients and Partners,

Thank you for your continued support of MarkerX. To align with our overall strategic direction and focus our resources on the development of early screening and major disease tracking technologies, as well as expanding our global presence, MarkerX will adjust its business operations, ceasing services of the Mass Spectrometry Division effective April 22, 2025.

For clients with existing maintenance agreements or unfulfilled orders, MarkerX remains committed to fulfilling our obligations to ensure your interests are protected. Our team will proactively contact affected parties to discuss subsequent arrangements and provide suitable solutions.

We appreciate your recognition of MarkerX’s core values of Care, Innovation, and Proactivity. We look forward to co-creating a brighter future for precision medicine together.

For any inquiries, please contact us during business hours (Monday to Friday, 9:00 AM – 6:00 PM CST / 1:00 AM – 10:00 AM UTC), via the following:

Tel: +886-2-7730-2526

Email: support@marker-x.com

Sincerely,

MarkerX